StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.27−0.02 (-0.47%)

Close on Nov 18, 2026Market cap $1.53BP/E –Yield –

Precigen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Precigen's revenue for the twelve months ending Jun 30, 2023 was $22.10M, up 43.1% year over year. For fiscal 2025 it was $9.68M, up 146.7% from the year before. Over ten years it grew -25.1% a year on average. The highest annual figure on record is $219.46M in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.68M+146.7%
FY2024Dec 31, 2024$3.93M-36.9%
FY2023Dec 31, 2023$6.23M-76.9%
FY2022Dec 31, 2022$26.91M+88.6%
FY2021Dec 31, 2021$14.27M-55.4%
FY2020Dec 31, 2020$31.99M-64.7%
FY2019Dec 31, 2019$90.72M-40.0%
FY2018Dec 31, 2018$151.18M-31.1%
FY2017Dec 31, 2017$219.46M+14.9%
FY2016Dec 31, 2016$190.93M+10.0%
FY2015Dec 31, 2015$173.61M+141.4%
FY2014Dec 31, 2014$71.93M+202.7%
FY2013Dec 31, 2013$23.76M+72.5%
FY2012Dec 31, 2012$13.77M+71.9%
FY2011Dec 31, 2011$8.01M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$54.98M+3011.4%
Q1 FY2026Mar 31, 2026$23.25M+1156.2%
Q2 FY2025Jun 30, 2025$856.00K-51.4%
Q1 FY2025Mar 31, 2025$1.34M-92.0%
Q2 FY2023Jun 30, 2023$1.77M-39.3%
Q1 FY2023Mar 31, 2023$1.85M-66.4%
Q4 FY2022Dec 31, 2022$1.76M-52.1%
Q3 FY2022Sep 30, 2022$16.72M+401.7%
Q2 FY2022Jun 30, 2022$2.91M-23.7%
Q1 FY2022Mar 31, 2022$5.51M-77.5%
Q4 FY2021Dec 31, 2021$3.68M-80.9%
Q3 FY2021Sep 30, 2021$3.33M-85.9%
Q2 FY2021Jun 30, 2021$3.82M-87.5%
Q1 FY2021Mar 31, 2021$24.51M-17.9%
Q4 FY2020Dec 31, 2020$19.33M+13.7%
Q3 FY2020Sep 30, 2020$23.58M+28.9%
Q2 FY2020Jun 30, 2020$30.42M-7.3%
Q1 FY2020Mar 31, 2020$29.84M+32.1%
Q4 FY2019Dec 31, 2019$17.00M-58.7%
Q3 FY2019Sep 30, 2019$18.30M-39.1%
Q2 FY2019Jun 30, 2019$32.84M-23.2%
Q1 FY2019Mar 31, 2019$22.59M-39.2%
Q4 FY2018Dec 31, 2018$41.19M-46.5%
Q3 FY2018Sep 30, 2018$30.06M-34.7%
Q2 FY2018Jun 30, 2018$42.77M-21.4%
Q1 FY2018Mar 31, 2018$37.16M-30.5%
Q4 FY2017Dec 31, 2017$77.03M+67.4%
Q3 FY2017Sep 30, 2017$46.02M-6.1%
Q2 FY2017Jun 30, 2017$54.43M–
Q1 FY2017Mar 31, 2017$53.50M–
Q4 FY2016Dec 31, 2016$46.00M–
Q3 FY2016Sep 30, 2016$48.99M–

More Precigen figures

See a number that looks wrong?